DoW Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
Closed Posted
- Opportunity number
- HT942526KCRPAKCIECSA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of the Army Medical Command is soliciting applications for the Kidney Cancer Research Program Academy of Kidney Cancer Investigators Early-Career Scholar Award, with a letter of intent deadline of September 14, 2026 and full application due September 28, 2026. Approximately $2.4 million will fund roughly 2 awards with a total cost cap of $1.2 million per award over a maximum 4-year period. No cost share is required.
Eligible applicants include extramural and intramural U.S. Department of War organizations, foreign and domestic organizations, and for-profit and nonprofit entities. The Early-Career Scholar principal investigator must be less than seven years from their last postdoctoral research position or clinical fellowship by the application submission deadline, must commit approximately 50 percent protected time for kidney cancer research and Academy activities, and must commit no less than 25 percent effort to the award for the first two years. Each Early-Career Scholar is paired with a Designated Mentor who has a strong record of successful mentorship coupled with strong funding and publications in kidney cancer research. If the Designated Mentor is located at a different institution than the Early-Career Scholar, an Other Mentor at the Early-Career Scholar's institution must also be included.
Applications must address at least one of seven specified KCRP focus areas and one kidney cancer disease type. Preliminary data supporting research feasibility is required; these data need not derive from the kidney cancer field. Clinical trials are prohibited. Applications undergo peer review assessing Early-Career Scholar potential, research strategy and feasibility, career development plan, Designated Mentor qualifications, and research impact, followed by programmatic review for alignment with KCRP priorities. Peer review is scheduled for December 2026 and programmatic review for March 2027, with awards anticipated by September 30, 2027.
Assistance Listing 12.420. Applications are submitted via a two-step process: Letter of Intent through eBRAP followed by full application through Grants.gov (extramural) or eBRAP (intramural).
Synopsis
Summary: Initially created in fiscal year 2019 (FY19), the Kidney Cancer Research Program (KCRP) Academy of Kidney Cancer Investigators (AKCI) is a unique interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The Academy pairs Early Career Scholars (ECS) with established investigators (Designated Mentors) under the oversight of the AKCI Leadership Team, a Designated Mentor Panel, and the Kidney Cancer Patient Advocates Panel. The AKCI's overarching goal is to conduct innovative and impactful kidney cancer research while also developing a vital resource, a network of highly productive kidney cancer researchers conducting cutting edge research that advances the state of the field in kidney cancer and leads to new treatments for individuals living with kidney cancer.
Distinctive Features:
· Early-Career Scholar: The FY26 KCRP AKCI-ECSA focuses on both the Scholar's
research and their career potential in the kidney cancer field.
· Designated Mentor: The Designated Mentor must have a strong record of successful mentorship coupled with a strong record of funding (past and present) and publications in kidney cancer research.
· Preliminary Data: Preliminary data to support the feasibility of the research and approaches are required; however, these data do not need to be derived from the kidney cancer research field.
Files
| File | Type | Posted |
|---|---|---|
| PKG00293376.pdf | ||
| HT942526KCRPAKCIECSA_GG2.pdf | ||
| HT942526KCRPAKCIECSA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity